Evidence map›Paper›PMID 37759081›Full record

ArticleScientific reports2023

Multidisciplinary management of acute cholecystitis during the COVID-19 pandemic.

I Tóth, S Ábrahám, Z Karamya, R Benkő, M Matuz, A Nagy, D Váczi, A Négyessy, B Czakó, D Illés and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Evaluating Surgical Outcomes in Acute Cholecystectomies.JSLS : Journal of the Society of Laparoendoscopic Surgeons
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

I TóthDepartment of Surgery, University of Szeged, Szeged, Hungary.
S ÁbrahámDepartment of Surgery, University of Szeged, Szeged, Hungary.
Z KaramyaDivison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary.
R BenkőDepartment of Clinical Pharmacology, University of Szeged, Szeged, Hungary.
M MatuzDepartment of Clinical Pharmacology, University of Szeged, Szeged, Hungary.
A NagyDepartment of Radiology, University of Szeged, Szeged, Hungary.
D VácziDepartment of Surgery, University of Szeged, Szeged, Hungary.
A NégyessyDepartment of Surgery, University of Szeged, Szeged, Hungary.
B CzakóDivison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary.
D IllésDivison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary.
M TajtiDivison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary.
E IványDivison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary.
G LázárDepartment of Surgery, University of Szeged, Szeged, Hungary.
László CzakóDivison of Gastroenterology, Department of Medicine, University of Szeged, Kálvária Sgt. 57., Szeged, 6725, Hungary. czako.laszlo@med.u-szeged.hu.
University of Szeged · HU

Funding

Géza Hetényi Research 5S 259Hungarian National Research, Development and Innovation Office K128222New National Excellence Programme, Hungarian Ministry of Human Capacities UNKP-22-2-SZTE-219
6 · The paper itself

Abstract

The coronavirus disease 2019 pandemic had a major impact on most medical services. Our aim was to assess the outcome of acute cholecystitis during the nationwide lockdown period. All patients admitted to our emergency department for AC were analysed. Patient characteristics, performance status, AC severity, treatment modality and outcome of AC were assessed during the lockdown period (Period II: 1 April 2020-30 November 2021) and compared to a historical control period (Period I: 1 May 2017-31 December 2018). AC admissions increased by 72.8% in Period II. Patients were younger (70 vs. 74 years, p = 0.017) and greater in number in the CCI 1 group (20.4% vs. 11.2%, p = 0.043) in Period II. The unplanned readmission rate (6.3 vs. 0%, p = 0.004) and the gallbladder perforation (GP) rate was higher (18.0 vs. 7.3%, p = 0.006) in Period II. Percutaneous transhepatic gallbladder drainage (PTGBD) was more frequent (24.1 vs. 12.8%, p = 0.012) in Period II. In addition to a drop in patient age and CCI, a significant rise in the prevalence of acute cholecystitis, GP and unplanned readmissions was observed during the nationwide lockdown due to the COVID-19 pandemic. PTGBD was more frequent during this period, whereas successful conservative treatment was less frequent.

Indexed as

Cholecystitis, AcuteCOVID-19Communicable Disease ControlDrainageGallbladderHumansPandemicsRetrospective StudiesTreatment Outcome

Identifiers

PMID37759081
PMCPMC10533883
OpenAlexW4387106923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.